A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Shanghai Henlius Biotech
Pfizer
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Biocon Limited
Bristol-Myers Squibb
Rapa Therapeutics LLC
Alvotech Swiss AG
Philogen S.p.A.
Philogen S.p.A.
Bristol-Myers Squibb
Qingdao Sino-Cell Biomedicine Co., Ltd.
Second Life Therapeutics
Aura Biosciences
Onchilles Pharma Inc
Alpha Tau Medical LTD.
AccSalus Biosciences, Inc.
OncoHost Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Biotroy Therapeutics
Ankyra Therapeutics, Inc
Boston Immune Technologies and Therapeutics
Oncodesign Precision Medicine
Xynomic Pharmaceuticals, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Power Life Sciences Inc.
Power Life Sciences Inc.